Stocks
Health Care
elvn
Enliven Therapeutics
NASDAQ: ELVN
+2.74 (+11.78%)
25.99
USD
At close at Jan 09, 21:43 UTC
Income Statement
Revenue
-
Gross Profit
-
Operating Income
-104.55M
Pretax Income
-97.21M
Net Income
-89.02M
EBITDA
-88.16M
EBIT
-88.79M
Earnings Per Share
-1.89
Balance Sheet
Cash & Cash Equivalents
117.75M
Total Debt
-
Net Cash
-
Net Cash Per Share
-
Equity (Book Value)
305.22M
Book Value Per Share
6.62
Working Capital
-
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.